Journal of Pharmacy and Pharmacology

Cover image for Vol. 66 Issue 9

Edited By: D Jones, Queen's University of Belfast, UK

Impact Factor: 2.161

ISI Journal Citation Reports © Ranking: 2013: 136/254 (Pharmacology & Pharmacy)

Online ISSN: 2042-7158

Associated Title(s): Pharmacy and Pharmacology Communications



Author Guidelines


Contacts for author queries:

Editorial Office (for submission queries and papers under review): JPPedoffice@wiley.com

Production Editor (for accepted and published papers only): jphp@wiley.com

Editorial Policy

Ithenticate LogoJournal of Pharmacy and Pharmacology employs a plagiarism detection system. By submitting your manuscript to the Journal you accept that your manuscript may be screened for plagiarism.


Journal of Pharmacy and Pharmacology considers all manuscripts on the strict condition that they have not been published already, nor are they under consideration for publication or in press elsewhere.

Journal of Pharmacy and Pharmacology publishes manuscripts pertaining to the design, delivery and mechanism of action of drugs and dosage forms with a view to developing and improving current therapeutic drug strategies. The Journal publishes original research papers, critical reviews, mini reviews and short communications.

Contributions to Journal of Pharmacy and Pharmacology will be subjected to review at the discretion of the Editorial Office and papers accepted may be subject to editorial revision. Decisions regarding acceptability will be made on the basis of the quality of science, the contribution of the work to the field, the suitability of the work for the Journal and the presentation of the manuscript. Contributions submitted by the Journal's Editors and Editorial Board members are subject to the same peer review standards as papers submitted by all other authors. We aim to present authors with an initial decision regarding the acceptability of submitted papers within ten weeks of receipt of the manuscript.

Manuscript Preparation  

General guidelines

  • All contributing authors of a manuscript should include their full name, affiliation, postal address, telephone and fax numbers and email address on the cover page of the manuscript. One author should be identified as the corresponding author.
  • For all manuscripts non-discriminatory (inclusive) language should be used.
  • Authors are urged to be succinct, to use the minimum number of tables and figures necessary and to avoid repetition of information between these two media. Given the competition for space within the journal, the length of submission in relation to its likely contribution will be taken into account with regard to acceptability. Guidelines on length are provided below.
  • The pages and lines of the manuscript must be numbered.

Ethical guidelines

  • Authors should supply a conflict of interest statement with their submitted manuscript, detailing any financial or personal relationships that may bias their work, or a declaration that they have no conflicts of interest to disclose.
  • Original research studies involving animals or human volunteers must include details of ethical approval. These should include:

    (a) the name of the Institutional Review Board or Ethics Committee that approved the study and all protocols,
    (b) the date of this approval and
    (c) the number of the certification or document which verified approval of the study.

    Identifying details of patients and study participants should be omitted. If identifying information is essential for scientific purposes, or if there is any doubt about the adequacy of the anonymity protection used, the patient (or parent/guardian) must give written informed consent for publication. Authors should provide this statement of informed consent upon submission of the manuscript.
  • Manuscripts reporting randomised controlled trials should include a checklist and flowchart in accordance with the CONSORT Statement guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.
  • Systematic reviews must be submitted together with a checklist and flowchart in accordance with the PRISMA guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.  

Further information can be found in our Ethical Guidelines document.

The use of Natural Products

In studies that describe the use of natural products, the source organism must be authenticated by an expert and include reference to appropriate voucher specimens. All organisms must be validated taxonomically (in case of non-cultivated plant species http://www.ipni.org/ or http://www.theplantlist.org/ need to be used.

Chemical Composition of Extracts from Natural Products

All extracts from natural products should be fullly characterised to ensure that full details of the chemical composition is known. For this purpose, separative methods (e.g. HPLC) following by structural elucidation methods are required (e.g. spectroscopy). Furthermore, an HPLC chromatograph should be included, where appropriate.

Language

Manuscripts are accepted only in English. Authors whose first language is not English are recommended to ask a native speaker to proofread their manuscript before submission. There are also a number of services that provide mentoring, advice and copyediting to support authors unfamiliar with writing academic research papers for publication in international journals. Authors are encouraged to make use of services such as AuthorAID if necessary.

Original research papers

Original research papers should not exceed 4000 words.  

Abstract

  • Structured abstracts are required for all papers and should include objectives, methods, key findings and conclusions.
  • Approximate length: 200 words

Keywords

  • Three to six keywords should be supplied for all papers.

Introduction

  • An introduction should provide a background to the study (appropriate for an international audience) and should clearly state the specific aims of the study. Please ensure that any abbreviations and all symbols used in equations are fully defined.
  • Approximate length: 500-1000 words  

Materials and Methods

  • This section should describe the materials and methods used in sufficient detail to allow the study to be replicated. Please include details of ethical approval in this section.
  • Approximate length: 500-1000 words  

Results

  • This section should provide detailed response rates. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Data should not be repeated in figures and tables.
  • Approximate length: 1000-1500 words  

Discussion

  • The discussion section should summarise the main findings of the study, followed by a critique of the strengths and limitations of the research. The results should then be discussed in the context of international published literature and the contribution made to the field. Any policy limitations should be included.
  • Approximate length: 1000 words    

Conclusions

  • A brief conclusions section should summarise the salient findings of the study. Authors are strongly advised to emphasise the contribution made to the field by their study in this section.
  • Approximate length: 200 words  

Tables

  • Please keep the number of tables to a minimum.
  • Tables should be numbered consecutively (Table 1, Table 2 etc) and each table must start on a separate page at the end of the manuscript.
  • Each table must have a title. Each table legend, in paragraph form, should briefly describe the content and define any abbreviations used. If values are cited in a table, the unit of measurement must be stated.
  • Tables should not be ruled.  

Figures

  • Please keep the number of figures to a minimum.  
  • Each figure must have a title. Each figure legend, in paragraph form, should briefly describe the content and define any abbreviations used. If values are cited in a figure, the unit of measurement must be stated. Graphs must have clearly labelled axes. A key may be included if appropriate.
  • It is in the author's interest to provide the highest quality figure format possible. Please be sure that all imported scanned material is scanned at the appropriate resolution: 1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour.
  • Files should be saved as one of the following formats: TIFF (tagged image file format), PostScript or EPS (encapsulated PostScript), and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC).
  • Figures must be saved separate to text. Please do not embed figures in the paper file. The manuscript should indicate the position of the figures (e.g. see Figure 1) and all figures should be numbered consecutively in the order in which they appear in the paper. In multi-part figures, each part should be labelled (e.g. Figure 1(a), Figure 1(b)). The filename for a graphic should be descriptive of the graphic, e.g. Figure1, Figure2a.
  • Authors must complete a Colour Work Agreement Form for any colour figures requiring payment. The form can be downloaded as a PDF* (portable document format) file from the home page here. Completed forms must be sent by post/mail to: Journal of Pharmacy and Pharmacology, John Wiley & Sons Ltd, European Distribution Centre, New Era Estate, Oldlands Way, Bognor Regis, West Sussex, PO22 9NQ. Authors should restrict their use of colour to situations where it is necessary on scientific, and not merely cosmetic, grounds. There are a limited number of colour pages within the journal’s annual page allowance to be used at the Editor’s discretion. *To read PDF files, you must have Acrobat Reader installed.  

Acknowledgements and Funding

  • Funding acknowledgements should be written in the following form: “This work was supported by the Medical Research Council [grant number xxx]”
  • If the research has not been funded by any specific project grant, please include the statement: “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors”  

References

  • References in the text are cited sequentially by number. All citations in the text must appear in the reference list and vice versa. The only exceptions to this are manuscripts not yet in press or published online, papers reported at meetings, or personal communications – these should be cited only in the text, not as a formal reference. Authors should get permission from the source to cite personal communications or unpublished work.
  • At the end of the manuscript, references should be listed in numerical order as they appear in the text. Serial titles should be abbreviated in accordance with the standard approved abbreviations used by PubMed or BIOSIS. One-word titles are never abbreviated. Article identifiers, such as the Digital Object Identifier (DOI) or PubMed Unique Identifier (PMID), may be included as appropriate. State the references according to the format of the following examples:  

Journal references

One author:
Szeto HH. Simultaneous determination of meperidine and normeperidine in biofluids. J Chromatogr 1976; 125: 503–510.  

Two authors:
Vu-Duc T, Vernay A. Simultaneous detection and quantitation of O6-monoacetylmorphine, morphine and codeine in urine by gas chromatography with nitrogen specific and/or flame ionization detection. Biomed Chromatogr 1990; 4(2): 65–69.  

Three or more authors: Huestis MA et al. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol 2000; 4(Suppl.3): 509–521.  

Article in press:
Ladines CA et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2008 (in press).  

Electronic publication ahead of print:
Teeuwen PHE. Doppler-guided intra-operative fluid management during major abdominal surgery: a systematic review and meta-analysis. Int J Clin Pract (accessed 21 November 2007, epub ahead of print).  

Online serial:
Margolis PA et al. From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children. Pediatrics [online] 2001; 108:e42. www.pediatrics.org/cgi/content/full/108/3/e42 (accessed 20 September 2001).  

Corporate author:
The Cardiac Society of Australia and New Zealand . Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164: 282–284.  

Anonymous author:
Anon. Coffee drinking and cancer of the pancreas. BMJ 1981; 283: 628.  

Author with prefix and/or suffix in their name:
Humphreys Jnr, Sir Robert and Adams T. Reference style in the modern age. J Bib Cit 2008; 1: 1–10.  

Article not in English:
Sokolov S et al. [Studies of neurotropic activity of new compounds isolated from Rhodiola rosea L.] Khim Farm Zh 1985; 19: 1367–1371 [in Russian].  

Book references

Book by a single author or group of authors working together as a single author:
Cole MD, Caddy B. The Analysis of Drugs of Abuse: An instruction manual, 2nd edn. New York : Ellis Horwood, 1995.  

An edited book:
Hoepfner E et al. eds. Fiedler Encyclopedia of Excipients for Pharmaceuticals, Cosmetics and Related Areas, 5th edn. Aulendorf: Editio Cantor Verlag, 2002.  

An article in an edited book:
Sanders PA. Aerosol packaging of pharmaceuticals. In: Banker GS, Rhodes CT , eds. Modern Pharmaceutics. New York : Marcel Dekker, 1979: 591–626.  

A book in a series:
Scott RPW. Chromatographic Detectors – Design, Function, and Operation. Chromatographic Science Series, 73, Cazes J, ed. New York : Mercel Dekker, 1966.  

Other references  

Article in conference proceedings:
Dumasia MC et al. LC/MS analysis of intact steroid conjugates: a preliminary study on the quantification of testosterone sulphate in equine urine. In: Auer DE, Houghton E, eds. Proceedings of the 11th International Conference of Racing Analysts and Veterinarians. Newmarket : R & W Publications ( Newmarket ), 1966: 188–194.  

Standard:
ISO 9002. Quality Systems – Model for Quality Assurance in Production, Installation and Servicing Quality Management System. Geneva : ISO, 1994.  

Offline database or publication:
Dictionary of Natural Products. CD-ROM. London : Chapman & Hall/CRC, 2003.  

Milazzo S et al. Laetrile treatment for cancer. Cochrane Database of Systematic Reviews, issue 2. London : Macmillan, 2006.  

Dissertation:
Youssef NM . School adjustment of children with congenital heart disease. Pittsburgh , Pennsylvania : University of Pittsburgh , 1988 (dissertation).  

Critical reviews
These are normally commissioned by invitation from the Editors but suggestions are welcome. Please contact the Editorial Office before submitting a review article.  

Mini reviews
These are discussion articles of up to 6000 words in length. Please contact the Editorial Office prior to submission of such articles.  

Short communications
Short reports of up to 2000 words (with a maximum of four figures and/or tables) that describe particularly pertinent findings may be submitted as a rapid communication that, once accepted, will receive publishing priority. Authors are asked to include a covering letter outlining why the paper merits rapid publication. Please note that this section is not intended for short studies per se but for findings that should be brought rapidly to the attention of the readership.  

Manuscript Submission

All submissions should be made online at the Journal of Pharmacy and Pharmacology ScholarOne Manuscripts site at http://mc.manuscriptcentral.com/jppharm. New users will first need to register. Once logged on to the site as an author, follow the instructions to submit your manuscript. An author tutorial and online help guide are available on this website.

Manuscripts may be submitted in any standard format, including Word, PDF, PostScript, WordPerfect, RTF, TEXT, LaTeX2e and AMSTex. Multiple files can be uploaded as a single zipped file. All files are automatically combined and converted into a PDF file for the review process. Authors are invited to suggest up to three potential reviewers, together with their contact details (e-mail addresses are essential).

Authors may also identify reviewers that should not be used due to potential conflict of interest, together with the justification for the request.

Copyright Transfer Agreement

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the copyright transfer agreement

If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions: http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen

If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

OnlineOpen

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp. Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

Peer Review Process

Initial editorial screening
Submissions will be examined by the Editor to ensure that the manuscript falls within the priority remit of the journal. Those papers that do not fall within this remit will be returned to the author as rapidly as possible to facilitate resubmission to a more suitable publication.

Submission to reviewers
The manuscript will be sent to suitable individuals working in the field who have agreed to review the paper. Authors who have suggested reviewers at the time of submission may usually expect one of these individuals to be contacted, assuming that full contact details have been provided (including email address). At least two sets of reviewers’ comments will be utilized.

Initial editorial decision
The Editor will appraise the manuscript in the light of the recommendations made by the reviewers. One of the following decisions will be made:

  • accept as received;
  • accept subject to satisfactory completion of minor amendments (an editorial report is usually included at this stage)  
  • reconsider after major revision (full revised manuscript requested)
  • reconsider after major revision (response to reviewer's comments requested prior to preparation of a full revised manuscript)
  • reject

Papers are judged not only on the presence or absence of flaws to the work, but also on the likely contribution to the field. Those manuscripts that represent only a small incremental increase in the respective knowledge base will not be accepted irrespective of whether the work has been conducted in a sound manner.

Following receipt of the revised paper and/or response to reviewers
The Editor reserves the right to make a decision on the paper without consulting the reviewers for a second time. Members of the Editorial Board may also be consulted at this stage. The final decision will be reported back to the author as quickly as possible. One of the following decisions will be made:

  • accept as received  
  • accept subject to satisfactory completion of requested revisions
  • reject

Authors are only entitled to revise their paper twice; if after the second revision the paper is still considered to be unacceptable for publication it will be rejected.

Accepted manuscripts sent to the Production Office
Accepted papers are forwarded to Wiley-Blackwell for processing. The paper may undergo copyediting for readability, consistency and formatting into the journal’s style prior to typesetting. PDF proofs will be sent by email to the Corresponding Author for checking; we ask that you return your corrected proofs as soon as possible. Failure to return the proof promptly will result in delays to the publication of the manuscript.

Authors may also be contacted at the copyediting and proofreading stages if queries arise during the production of their manuscript.

Reviewers are thanked and given the opportunity to view the final decision. Once a final decision has been made regarding a manuscript, reviewers have access to this decision and to view the other reviewers’ reports for that manuscript.

Proofreading guide

Authors should check their proofs for the following:

  • Typesetting or conversion errors
  • Figures and tables – position in the text, accurate reproduction and correct legend
  • Editing - language, house style, scientific nomenclature

There may be a list of queries attached to your proofs; if so, please make sure that all queries are answered and that the answers are returned with the marked proof.

Marking clear corrections:

  • To delete a character, word or block of text, cross out the material and write 'delete' in the margin.
  • If something has been marked for deletion and you decide to retain it, underscore the material in the text and write 'stet' in the margin.
  • If you wish to add some text, place a Y in the text and write the addition in the margin. If there is not enough room for the addition please attach a separate sheet and indicate clearly where it should be inserted in the text.

Supporting Information (online only)

Additional material such as video clips, lengthy Appendices (e.g. extensive reference lists or mathematical formulae/calculations), etc, that are relevant to a particular article but not suitable or essential for the print edition of the Journal, may also be considered for publication. Please refer to all supporting information in the manuscript using Table S1, Figure S1, etc, and supply such information as separate files (i.e. not embedded within the main manuscript). Further information on suitable file formats etc may be found here.

Author Service

Online production tracking is available for your article through Wiley-Blackwell's Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit Wiley-Blackwell Author Services  for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more. For more substantial information on the services provided for authors, please see Wiley-Blackwell Author Services.

Early View

Journal of Pharmacy and Pharmacology is covered by Wiley-Blackwell’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

SEARCH

SEARCH BY CITATION